estrone has been researched along with Atypical Endometrial Hyperplasia in 28 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Atypical Endometrial Hyperplasia: A benign form of endometrial hyperplasia with increased number of cells with atypia. The atypical cells are large and irregular and have an increased nuclear/cytoplasmic ratio. The risk of progression to endometrial carcinoma rises with the increasing degree of cell atypia.
Excerpt | Relevance | Reference |
---|---|---|
"A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 7.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 7.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 5.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
"A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 3.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 3.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 1.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (78.57) | 18.7374 |
1990's | 2 (7.14) | 18.2507 |
2000's | 3 (10.71) | 29.6817 |
2010's | 1 (3.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lobo, RA | 1 |
Liu, J | 1 |
Stanczyk, FZ | 1 |
Constantine, GD | 1 |
Pickar, JH | 2 |
Shadiack, AM | 1 |
Bernick, B | 1 |
Mirkin, S | 1 |
Bochkareva, NV | 1 |
Kolomiets, LA | 1 |
Kondakova, IV | 1 |
Stukanov, SL | 1 |
Tropina, TV | 1 |
Muntian, AB | 1 |
POLISHUK, WZ | 1 |
PLUNKETT, ER | 1 |
KASE, N | 1 |
Deng, L | 1 |
Broaddus, RR | 1 |
McCampbell, A | 1 |
Shipley, GL | 1 |
Loose, DS | 1 |
Stancel, GM | 1 |
Davies, PJ | 1 |
Goldzieher, JW | 1 |
Fariss, B | 1 |
Prost, O | 1 |
Adessi, GL | 1 |
Pelusi, G | 1 |
Moretti, B | 1 |
Martinelli, G | 1 |
Camerini, T | 1 |
Busacchi, P | 1 |
Cavallina, R | 1 |
Kasai, T | 1 |
Takeda, B | 1 |
Takamizawa, H | 1 |
Scirpa, P | 1 |
Mango, D | 1 |
Battaglia, F | 1 |
Scirpa, S | 1 |
Montemurro, A | 1 |
Forney, JP | 1 |
Milewich, L | 1 |
Chen, GT | 1 |
Garlock, JL | 1 |
Schwarz, BE | 1 |
Edman, CD | 2 |
MacDonald, PC | 2 |
James, VH | 2 |
Reed, MJ | 2 |
Folkerd, EJ | 1 |
Klemi, PJ | 1 |
Grönroos, M | 1 |
Rauramo, L | 1 |
Punnonen, R | 1 |
Niwa, K | 1 |
Murase, T | 1 |
Furui, T | 1 |
Morishita, S | 1 |
Mori, H | 2 |
Tanaka, T | 1 |
Tamaya, T | 1 |
Rebar, RW | 1 |
Trabal, J | 1 |
Mortola, J | 1 |
Whitehead, MI | 2 |
Badawy, SZ | 1 |
Elliott, LJ | 1 |
Elbadawi, A | 1 |
Marshall, LD | 1 |
Grodin, JM | 1 |
Vellios, F | 1 |
Siiteri, PK | 1 |
Brush, MG | 1 |
Milton, PJ | 1 |
Swain, M | 1 |
Moore, J | 1 |
Harris, ST | 1 |
Genant, HK | 1 |
Baylink, DJ | 1 |
Gallagher, JC | 1 |
Karp, SK | 1 |
McConnell, MA | 1 |
Green, EM | 1 |
Stoll, RW | 1 |
Jasonni, VM | 3 |
Franceschetti, F | 1 |
Ciotti, P | 3 |
Bulletti, C | 3 |
Vignudelli, A | 2 |
Marabini, A | 1 |
Naldi, S | 2 |
Flamigni, C | 3 |
Tabanelli, S | 1 |
Cappuccini, F | 1 |
Borini, A | 1 |
La Marca, L | 1 |
Beranek, PA | 1 |
Ghilchik, MW | 1 |
Rader, MD | 1 |
Flickinger, GL | 1 |
DeVilla, GO | 1 |
Mikuta, JJ | 1 |
Mikhail, G | 1 |
Markovski, N | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms[NCT00603967] | 151 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 trials available for estrone and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).
Topics: Adult; Aged; Biological Availability; Endometrial Hyperplasia; Estradiol; Estrone; Female; Hot Flash | 2019 |
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Endometrial Hyperplasia; Endometrial Neopla | 2005 |
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.
Topics: Double-Blind Method; Endometrial Hyperplasia; Equilin; Estrogen Replacement Therapy; Estrone; Female | 2000 |
The effects of estrone (Ogen) on spinal bone density of postmenopausal women.
Topics: Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Endometrial Hyperplasia; Estron | 1991 |
24 other studies available for estrone and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
[Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Topics: Androstenedione; Aromatase; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrone; Fema | 2008 |
A case of pyometra due to prolonged oestrone administration.
Topics: Endometrial Hyperplasia; Estrone; Female; Humans; Pyometra; Suppuration; Uterus | 1963 |
DRUGS FOR FUNCTIONAL UTERINE BLEEDING.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dosage Forms; Drug Therapy; Dydroges | 1964 |
STEROID SYNTHESIS IN ABNORMAL OVARIES. II. GRANULOSA CELL TUMOR.
Topics: Androgens; Chromatography; Corpus Luteum Hormones; Dehydroepiandrosterone; Endometrial Hyperplasia; | 1964 |
The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Topics: 17-Ketosteroids; Adrenal Glands; Adult; Androgens; Chromatography; Cysts; Endometrial Hyperplasia; E | 1967 |
Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies.
Topics: Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrial Hyperplasia; Endometrium; Estron | 1983 |
Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Endometrial Hyperplasia; Estradiol; Estro | 1983 |
[Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach].
Topics: Adult; Aged; Cytodiagnosis; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged | 1984 |
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F | 1982 |
Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia.
Topics: Adipose Tissue; Adult; Aged; Aging; Androstenedione; Aromatase; Endometrial Hyperplasia; Estrone; Fe | 1981 |
Studies of oestrogen metabolism in postmenopausal women with cancer.
Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estra | 1981 |
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge | 1980 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
The effects of oestrogens and progestogens on the postmenopausal endometrium.
Topics: Endometrial Hyperplasia; Endometrium; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M | 1978 |
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal | 1979 |
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe | 1976 |
Proceedings: Endocrine factors in the aetiology of cystic hyperplasia of endometrium.
Topics: Adult; Cysts; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating H | 1975 |
Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Endometrial Hyperplasia; Es | 1986 |
Prevention of endometrial abnormalities.
Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female | 1986 |
Increased extraction of estrogens in human endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Estradiol; Estrone; Female; Humans; Perfusion; | 1988 |
Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
Topics: Danazol; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged; Pregnadienes | 1986 |
Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Me | 1986 |
Plasma estrogens in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Castration; Diabetes Mellitus; Endometrial Hyperplasia; Endom | 1973 |
[Results of treatment of juvenile hemorrhagic metropathy with the authors method of hormone therapy, consisting of a combination of estrogen and progesterone].
Topics: Curettage; Drug Synergism; Endometrial Hyperplasia; Estrone; Female; Humans; Menorrhagia; Metrorrhag | 1973 |